Altermune Technologies' Seed Round

Altermune Technologies raised a round of funding on September 22, 2011. Investors include Loxbridge Research.

Altermune Technologies develops therapeutics to combat drug-resistant pathogens such as MRSA, C. difficile, pseudomonas, and pandemic influenza.…

Articles about Altermune Technologies' Seed Round: